Summary.-The transplantability of a xenografted human adenocarcinoma has been examined in mice that had been immune-suppressed by thymectomy and whole -body irradiation and the results have been compared with transplantation into athymic (nude) mice. Two alternative techniques were used to prevent marrow failure following whole-body irradiation: reconstituting the animals with a marrow graft, or protecting them by an injection of cytosine arabinoside (Ara-C) 2 days before the irradiation. The results show that the Ara-C-prepared mice were more receptive to transplantation than marrow-grafted or nude mice, and they were the only animals that developed regional metastases from implanted xenografts. Some recovery of immunity occurred in both types of immune-suppressed mice, which was evident more than 5 weeks after immune-suppression and which was more marked in females than in males. It was concluded that the immune-suppressed mice were superior to nude mice for short-term experiments but they may be less satisfactory for long-term experiments.
DURING the past 5 years we have been engaged in a programme of research on the growth and response to treatment of human tumours grafted into immunesuppressed mice. The results that we have published so far (Pickard, Cobb and Steel, 1975; Kopper and Steel, 1975; Courtenay et al., 1976) were obtained with mice that had been immune-suppressed by a standard technique of thymectomy, wholebody irradiation, and marrow reconstitution. Within the past 18 months we have explored methods of improving the level of immune suppression, and this paper describes our results.
MATERIAL AND METHODS
Original method of immune suppression.-The original technique involved thymectomy at 3-4 weeks of age. Male and female mice of the Institute of Cancer Research colony of CBA/lac mice were used, and have continued to be employed throughout the work described here. The thymectomy was performed under ether anaesthesia. The mouse was laid out in a supine position, head towards the operator, and a 5-7 mm incision was made in the skin overlying the suprasternal notch. The neck muscles were pulled apart with 2 pairs of forceps and the sternum was split to a distance of 3 mm using sharppointed scissors. The 2 lobes of the thymus could then be easily seen and were quickly sucked out through a glass tube connected via a glass collecting-chamber to a rotary vacuum pump. Finally, the skin was closed with a single metal Michel clip, and the animal was immediately placed in a warm box while it recovered from the anaesthetic. A skilled operator could perform a thymectomy by this technique in about 1 min, with an operative mortality of less than 500.
Two weeks after thymectomy the mice were given 900 rad whole-body irradiation from a 60Co source, and on the same day they received an i.v. injection of syngeneic marrow cells. The standard inoculum of nucleated marrow cells was in excess of 5 x 106. Marrow from non-thymectomized donors was used, on the basis of the work of Miller, Doak and Cross (1963) . Tumour implantation was usually performed 2-4 weeks after reconstitution.
This standard procedure formed the basis of all our early work in this area. It provided mice that allowed over 30 human tumours to be successfully grafted and in some cases repeatedly transplanted for up to 20 passages.
Effect of the size of the marrow graft.-Our suspicions that the immune-suppression technique was not optimal were raised by the observation that the receptivity of mice to xenografting varied from one operator to another, and that it appeared to depend upon the number of marrow cells used for reconstitution of the lethally irradiated mice.
For the present work we selected 2 lines of human tumour xenografts as our standard transplantation test svstems. Most of the work has been performed on a passaged tumour line that was originally started by Dr R. G. Pickard in 1973. The tumour came from a male patient who was found at operation to have widespread metastases within the peritoneum, which in the opinion of the surgeon originated from a large mass in the pancreas. The histopathological appearance was of a poorly differentiated adenocarcinoma that was consistent with carcinoma of the pancreas but which did not allow a conclusive diagnosis. After a long period of "silent" growth in the first passage this xenograft has grown quickly, and can be prepared as a cell suspension on enzyme treatment with collagenase and trypsin. The cells give a high plating efficiency when cultured in soft agar and this tumour was therefore used for the radiobiological studies reported by Courtenay et al. (1976) . This xenograft has now been designated HX32 and the number of HX32 cells required for intramuscular takes has been used as an index of the level of immune suppression of recipient mice. Tumours used in the present studies were in their 12th to 21st passages in immune-suppressed mice. (Hersch, 1973) and tests were therefore made of the effect on the take-rate of xenografts of retreating marrow-reconstituted immunesuppressed mice with CY shortly before implantation. The mice in these experiments were reconstituted with 5 x 106 marrow cells. Various xenograft lines were used and in each case a modest improvement in take-rate seemed to be associated with the CY pretreatment. As an example, mice were given i.m. injections of a brei of HX32 tumour tissue, made by chopping the tissue finely, mixing it with 10 vols of tissue culture medium and forcing it through needles of decreasing diameter. When 0-1 ml volumes of this brei were implanted 2 days after the mice had received i.p. injections of 200 mg/kg CY, the takes increased from 22/40 (55 %) to 26/32 (81 %).
RESULTS
A second example of the effect of additional immune-suppression by CY is shown in Fig. 1 . For this test we employed a different xenograft line, the HX1 8 tumour described by Pickard et al. (1975) and Kopper and Steel (1975) . For this tumour a cell-titration experiment had already been performed (see Chart 3 in Kopper and Steel, 1975) (Millar, Hudspith and Blackett, 1975; Millar, 1976 Fig. 3 shows how the proportion of mice developing one or more tumours depended upon the interval between the immune-suppressive irradiation and the implantation of tumour cells. For the greater part of this study thymectomy was performed at 4 weeks of age and irradiation was given 2 weeks later. Altogether, the results from 383 mice are included in this chart, which shows no significant difference between the takerate for marrow-reconstituted or Ara-Ctreated mice. Adding the results from both methods of preparation, tumour growth occurred in 218/227 mice when implants were made up to 5 weeks after irradiation. Thereafter the take-rate fell to reach a level of about 10 -4000 beyond the 9th week. The results obtained from male and female mice show that the take-rate for males remained rather higher than that for females.
The effect of changing the interval between thymectomy and irradiation has also been examined. Male mice were kept for periods up to 20 weeks after thymectomy; the irradiation was then given using Ara-C protection and the implanta- tion was performed up to 5 weeks later. There was a consistently high take-rate, indicating that a delay between thymectomy and irradiation did not prevent the irradiation from being fully effective in inducing immune suppression (Table II) .
On the basis of these data our standard procedure is now to hold mice in stock after thymectomy at 3-4 weeks of age and then to complete the preparation by giving Ara-C and irradiation a few days before they are required for transplantation.
Metastasis of xenografts in Ara-C-pretreated mice Spontaneous metastasis of xenografts had not been seen in our laboratory until the present programme using Ara-Cpretreated mice was begun. Our colleague, Dr Robert George, performed a series of experiments in which HX32 cells were injected i.v. into mice that had been reconstituted with 5 x 106 marrow cells, and he failed to detect the formation of lung colonies.
However, since our change from marrow reconstitution to Ara-C protection, metastases have been observed in mice with large bilateral i.m. HX32 tumours. These were killed when the tumours measured -2 cm diameter (20-23 days after implantation). Five out of 10 mice that had been immune-suppressed using Ara-C developed one or more enlarged lymph nodes in the lower para-aortic region. On histological examination, these nodes were found to be partially or completely replaced by tumour tissue. (Fig. 3) indicate that there was a period of 5 weeks after immune suppression when the receptivity of the mice to grafting was good. The subsequent loss of receptivity was more marked in female than in male mice. The length of the period of high receptivity might be shorter if a more sensitive test had been used (i.e. a smaller inoculum of tumour cells). With a less sensitive test the period might be longer. This loss of immune suppression may be a serious problem in some types of work with xenografted tumours. It may, for instance, help to explain the low takerate of many primary human tumour xenografts in immune-suppressed mice, if their growth rate was insufficient to beat the returning host immunity. In a series of tumour-control experiments with the HX32 tumour we have found no recurrences beyond the 6th week, as if tumours that suffered a large reduction in cell numbers were more likely to be overwhelmed by the host response. We are at present exploring methods of re-inducing the immune suppression.
The effect of lethally irradiated cells in improving the take-rate of viable tumour cells is a well-described phenomenon (Revesz, 1958) . It has been claimed by Peters and Hewitt (1974) to be due to the induction of a local clotting mechanism that prevents the escape of viable cells from the implantation site and their subsequent exposure to systemic host defence mechanisms. Their action in also swamping local defence mechanisms cannot be ruled out. In the present experiments the addition of lethally irradiated cells significantly improved the take-rate of the HX32 xenograft line. We are inclined to attribute our earlier failure to observe this effect with the HX18 line (Kopper and Steel, 1975) to the fact that the mice used at that time were suboptimally immune-suppressed.
The incidence of local and distant metastases in mice prepared by Ara-C protection is encouraging, and this phenomenon is now being studied in more detail. In conjunction with the higher take-rates, it leads us to believe that the Ara-C technique is a useful new method of immune suppression. By eliminating the need for a marrow graft it has the advantage of technical simplicity, and not unimportant is the fact that, in this Institute, the cost of breeding and preparing immune-suppressed mice is now about one-quarter of the cost of nude mice. Such considerations are, of course, secondary to the question of whether the mice are satisfactory hosts for the study of the growth and treatment response of human tumours, and in our judgement the choice between immunesuppressed and nude mice is from this standpoint still an open one. The present work suggests that for relatively shortterm experiments, for instance those involving cell-survival measurements (Courtenay et al., 1976) , the immunesuppressed mice may be superior, while for long-term experiments the nude mice have the advantage. Blackett, to whom we are grateful for advice on the Ara-C-protection technique.
